XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Class A common stock
Class B common stock
Class C common stock
Class A-3 Units
Class A-2 Units
Class A-1 Units
Common units
Preferred Stock
Common Stock
Class A common stock
Common Stock
Class B common stock
Common Stock
Class C common stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Retained Earnings (Accumulated Deficit)
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Total Stockholders' Equity
Total Stockholders' Equity
Cumulative Effect, Period of Adoption, Adjustment
Noncontrolling Interests
Noncontrolling Interests
Cumulative Effect, Period of Adoption, Adjustment
Member Units
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                            
Equity-based compensation $ 11                                         $ 11
Net income (loss) 2,660                                          
Beginning balance (in shares) at Dec. 31, 2020           376,395 225,972 296,302 78,717                          
Beginning balance at Dec. 31, 2020           $ 260,428 $ 154,286 $ 202,045 $ 47,757                          
Increase (Decrease) in Temporary Equity [Roll Forward]                                            
Preferred distributions, paid in-kind (in shares)           13,457 8,079 10,593                            
Preferred distributions, paid in-kind           $ 11,037 $ 6,778 $ 8,882                            
Change in temporary equity redemption value 142,036         $ 48,307 $ 35,276 $ 46,374 $ 12,079                          
Ending balance (in shares) at Mar. 31, 2021           389,852 234,051 306,895 78,717                          
Ending balance at Mar. 31, 2021           $ 319,772 $ 196,340 $ 257,301 $ 59,836                          
Beginning balance (in shares) at Dec. 31, 2020                                           53,105
Beginning balance at Dec. 31, 2020 (621,903)                           $ (623,342)             $ 1,439
Increase (Decrease) in Members' Equity [Roll Forward]                                            
Preferred distributions, paid in-kind (26,697)                           (26,697)              
Change in temporary equity redemption value (142,036)                           (142,036)              
Equity-based compensation (in shares)                                           1,762
Equity-based compensation 11                                         $ 11
Net Income (Loss) 2,660                           2,660              
Ending balance (in shares) at Mar. 31, 2021                                           54,867
Ending balance at Mar. 31, 2021 (787,965)                           (789,415)             $ 1,450
Ending balance (in shares) at Dec. 31, 2021     84,803,687 0 47,595,455           86,373,596   47,595,455                  
Ending balance at Dec. 31, 2021 878,963 $ 279               $ 0 $ 9 $ 0 $ 0 $ 764,366 (186,022) $ 238 $ (15,535) $ 562,818 $ 238 $ 316,145 $ 41  
Beginning balance (in shares) at Dec. 31, 2020           376,395 225,972 296,302 78,717                          
Beginning balance at Dec. 31, 2020           $ 260,428 $ 154,286 $ 202,045 $ 47,757                          
Beginning balance (in shares) at Dec. 31, 2020                                           53,105
Beginning balance at Dec. 31, 2020 $ (621,903)                           (623,342)             $ 1,439
Increase (Decrease) in Members' Equity [Roll Forward]                                            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-02 [Member]                                          
Cumulative ASC 842 adoption effect $ 878,963 $ 279               0 $ 9 0 $ 0 764,366 (186,022) $ 238 (15,535) 562,818 $ 238 316,145 $ 41  
Equity-based compensation 2,875                         1,783       1,783   1,092    
Shares withheld related to net share settlement of equity awards (55)                               (55) (55)        
Dilution                           (394)       (394)   394    
Distribution (1,373)                                     (1,373)    
Net income (loss) (22,606)                           (13,974)     (13,974)   (8,632)    
Ending balance (in shares) at Mar. 31, 2022     84,790,164 0 47,595,455           86,373,596   47,595,455                  
Ending balance at Mar. 31, 2022 858,083                 0 $ 9 0 $ 0 765,755 (199,758)   (15,590) 550,416   307,667    
Increase (Decrease) in Temporary Equity [Roll Forward]                                            
Change in temporary equity redemption value 0                                          
Increase (Decrease) in Members' Equity [Roll Forward]                                            
Equity-based compensation 2,875                         1,783       1,783   1,092    
Net Income (Loss) (13,974)                                          
Cumulative ASC 842 adoption effect $ 858,083                 $ 0 $ 9 $ 0 $ 0 $ 765,755 $ (199,758)   $ (15,590) $ 550,416   $ 307,667